A.R.T. Advisors’s Medifast MED Stock Holding History

A.R.T. Advisors’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-14,333	Closed	-$1.84M	–	1600
2019 Q2	$1.84M	Buy	14,333 +8,300	+138%	+$1.15M	0.1%	254
2019 Q1	$770K	Sell	6,033 -2,415	-29%	-$306K	0.05%	580
2018 Q4	$1.06M	Sell	8,448 -2,500	-23%	-$428K	0.07%	427
2018 Q3	$2.42M	Buy	10,948 +3,800	+53%	+$770K	0.11%	249
2018 Q2	$1.14M	Sell	7,148 -14,700	-67%	-$1.88M	0.05%	584
2018 Q1	$2.04M	Buy	+21,848	New	+$1.63M	0.08%	374
2017 Q4	–	Sell	-15,048	Closed	-$893K	–	1553
2017 Q3	$893K	Buy	+15,048	New	+$749K	0.05%	588
2017 Q2	–	Sell	-10,920	Closed	-$484K	–	1594
2017 Q1	$484K	Buy	+10,920	New	+$470K	0.02%	818
2015 Q2	–	Sell	-10,623	Closed	-$318K	–	1614
2015 Q1	$318K	Buy	+10,623	New	+$337K	0.01%	1091
2013 Q3	–	Sell	-10,404	Closed	-$268K	–	1409
2013 Q2	$268K	Buy	+10,404	New	+$273K	0.01%	1070

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

A.R.T. Advisors's MED Position: Q3 2019 in Review

A.R.T. Advisors sold out of Medifast (MED) in Q3 2019, closing a stake of 14,333 shares — an estimated $1.84M sold.

A.R.T. Advisors first reported a position in MED in Q2 2013 and held it in 10 quarters. The position peaked at $2.42M in Q3 2018. 239 funds tracked by Wall St. Rank hold MED as of Q3 2019.

A.R.T. Advisors reported no remaining Medifast position as of Q3 2019 after selling out during the quarter.
A.R.T. Advisors sold 14,333 Medifast shares in Q3 2019, an estimated $1.84M.
A.R.T. Advisors first reported a position in Medifast in Q2 2013 and held it in 10 quarters.
A.R.T. Advisors's Medifast position peaked at $2.42M in Q3 2018.
239 funds tracked by Wall St. Rank held Medifast as of Q3 2019.

Based on A.R.T. Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.